These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16412098)

  • 1. Substrate-mediated enhancement of phosphorylated tyrosine hydroxylase in nigrostriatal dopamine neurons: evidence for a role of alpha-synuclein.
    Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL
    J Neurochem; 2006 Feb; 96(4):950-9. PubMed ID: 16412098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice.
    Mitsumoto Y; Watanabe A; Mori A; Koga N
    Biochem Biophys Res Commun; 1998 Jul; 248(3):660-3. PubMed ID: 9703982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of neuronal inclusions combined with increased nigral expression of alpha-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice.
    Fornai F; Lenzi P; Ferrucci M; Lazzeri G; di Poggio AB; Natale G; Busceti CL; Biagioni F; Giusiani M; Ruggieri S; Paparelli A
    Brain Res Bull; 2005 May; 65(5):405-13. PubMed ID: 15833595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of striatal tyrosine hydroxylase phosphorylation by acute and chronic haloperidol.
    Håkansson K; Pozzi L; Usiello A; Haycock J; Borrelli E; Fisone G
    Eur J Neurosci; 2004 Aug; 20(4):1108-12. PubMed ID: 15305880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.
    Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL
    Neurotoxicology; 2004 Sep; 25(5):761-9. PubMed ID: 15288507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated dopamine storage increases the vulnerability to α-synuclein in nigral neurons.
    Ulusoy A; Björklund T; Buck K; Kirik D
    Neurobiol Dis; 2012 Sep; 47(3):367-77. PubMed ID: 22659302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of alpha-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson's disease rat model.
    Hayashita-Kinoh H; Yamada M; Yokota T; Mizuno Y; Mochizuki H
    Biochem Biophys Res Commun; 2006 Mar; 341(4):1088-95. PubMed ID: 16460685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of phosphorylated alpha-synuclein in dopaminergic neurons of transgenic mice that express human alpha-synuclein.
    Wakamatsu M; Ishii A; Ukai Y; Sakagami J; Iwata S; Ono M; Matsumoto K; Nakamura A; Tada N; Kobayashi K; Iwatsubo T; Yoshimoto M
    J Neurosci Res; 2007 Jun; 85(8):1819-25. PubMed ID: 17465029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
    Alvarez-Fischer D; Henze C; Strenzke C; Westrich J; Ferger B; Höglinger GU; Oertel WH; Hartmann A
    Exp Neurol; 2008 Mar; 210(1):182-93. PubMed ID: 18053987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
    Chu Y; Kordower JH
    Neurobiol Dis; 2007 Jan; 25(1):134-49. PubMed ID: 17055279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prosurvival effect of human wild-type alpha-synuclein on MPTP-induced toxicity to central but not peripheral catecholaminergic neurons isolated from transgenic mice.
    Pérez-Sánchez F; Milán M; Buendía P; Cano-Jaimez M; Ambrosio S; Rosenthal A; Fariñas I
    Neuroscience; 2010 May; 167(2):261-76. PubMed ID: 20156526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical investigations of dopamine neuronal systems in iron-regulatory protein 2 (IRP-2) knockout mice.
    Salvatore MF; Fisher B; Surgener SP; Gerhardt GA; Rouault T
    Brain Res Mol Brain Res; 2005 Oct; 139(2):341-7. PubMed ID: 16051392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
    Liu LX; Chen WF; Xie JX; Wong MS
    Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of haloperidol and melatonin on the in situ activity of nigrostriatal tyrosine hydroxylase in male Syrian hamsters.
    Vriend J; Dreger L
    Life Sci; 2006 Mar; 78(15):1707-12. PubMed ID: 16263138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin inhibits amphetamine-induced increase in alpha-synuclein and decrease in phosphorylated tyrosine hydroxylase in SK-N-SH cells.
    Klongpanichapak S; Phansuwan-Pujito P; Ebadi M; Govitrapong P
    Neurosci Lett; 2008 May; 436(3):309-13. PubMed ID: 18406059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of α-synuclein upregulates tyrosine hydroxylase activity in MN9D cells.
    Wu B; Liu Q; Duan C; Li Y; Yu S; Chan P; Uéda K; Yang H
    Acta Histochem; 2011 Jan; 113(1):32-5. PubMed ID: 19683335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tyrosine hydroxylase expression in alpha-synuclein-transfected dopaminergic neuronal cells.
    Yu S; Zuo X; Li Y; Zhang C; Zhou M; Zhang YA; Uéda K; Chan P
    Neurosci Lett; 2004 Aug; 367(1):34-9. PubMed ID: 15308292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of local (intracerebral and intracerebroventricular) administration of tyrosine hydroxylase inhibitor on the neuroendocrine dopaminergic neurons and prolactin release.
    Bodnár I; Hechtl D; Székács D; Oláh M; Nagy GM
    Ideggyogy Sz; 2007 Mar; 60(3-4):177-81. PubMed ID: 17451064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased sensitivity to MPTP in human alpha-synuclein A30P transgenic mice.
    Nieto M; Gil-Bea FJ; Dalfó E; Cuadrado M; Cabodevilla F; Sánchez B; Catena S; Sesma T; Ribé E; Ferrer I; Ramírez MJ; Gómez-Isla T
    Neurobiol Aging; 2006 Jun; 27(6):848-56. PubMed ID: 16006012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegenerative alterations in the nigrostriatal system of trkB hypomorphic mice.
    Zaman V; Nelson ME; Gerhardt GA; Rohrer B
    Exp Neurol; 2004 Dec; 190(2):337-46. PubMed ID: 15530873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.